Skip to content

Management of Type 2 Diabetes through Yoga and Ayurveda

A Randomised control trial for the mechanism of action of Yoga and Ayurveda with Yoga in Type-2 Diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017500
Enrollment
120
Registered
2019-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: AYUSH-82 extract tablet: 4 tablets per day (2 in the morning, 2 at night), for a period of 6 months Intervention2: Yoga: Standardized Yoga Module for Type-2 Diabetes Mellitus practised

Sponsors

Jivanti Welfare and Charitable Trust
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Known / diagnosed Type-2 diabetics picked up from screened population with >60 score on IDRS Gender: Both male and female Age: 25-75 years Without hypertension and obesity Those on oral hypo glycemic drugs; Metformin & Glimepiride only Subjects with HbA1C � 6.4%

Exclusion criteria

Exclusion criteria: Morbid Obesity [BMI � 40 kg/m2] Subjects with conditions such as uncontrolled hypertension (persistent BP > 180/ 100 mm of Hg after two consecutive recordings and also by checking from their earlier medical records) or severe range of obesity [BMI � 40 kg/m2] History of a major/ minor surgery in the past 3 months. History of tuberculosis within past 3 years. History of head injury, neurological or psychiatric disorder in the past Pregnancy and lactation Unable to perform Yoga

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose HbA1C Pro insulin Insulin C peptide Timepoint: Baseline and End of Study (After 3 months)

Secondary

MeasureTime frame
Lipid Profile Liver Function tests Kidney function tests Glucagon Somatostatin Pancreatic polypeptide GLP1 and GIP Acetylcholine Malonyl CoA Free Fatty Acid Analysis Leptin Adiponectin Timepoint: Baseline and End of Study (After 3 months)

Countries

India

Contacts

Public ContactDr Amit Singh

Vivekananda Yoga Anusandhana Samsthana

rnagaratna@gmail.com08022639953

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026